Neuroprotective Effect of CT1812 in a Mouse Model of Ocular Hypertension

Project Details

StatusFinished
Effective start/end date1/04/21 → 31/03/24

Funding

  • Cognition Therapeutics, Inc.: $70,683.00

Keywords

  • Aging & Alzheimers, Biotechnology & Drug Development, Neurosciences, Vision Research